Literature DB >> 18823040

Normal dopamine transporter single photon-emission CT scan in corticobasal degeneration.

Sean S O'Sullivan, David J Burn, Janice L Holton, Andrew J Lees.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18823040     DOI： 10.1002/mds.22323

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  9 in total

1.  Dual-phase 18F-FP-CIT PET in corticobasal syndrome underlying AD pathology.

Authors:  Jung Han Yoon; Young Sil Ahn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-04       Impact factor: 9.236

2.  Normal dopamine transporter SPECT in neuropathologically confirmed corticobasal degeneration.

Authors:  Valtteri Kaasinen; Maria Gardberg; Matias Röyttä; Marko Seppänen; Markku Päivärinta
Journal:  J Neurol       Date:  2013-03-08       Impact factor: 4.849

Review 3.  Nuclear Imaging in the Diagnosis of Clinically Uncertain Parkinsonian Syndromes.

Authors:  Ralph Buchert; Carsten Buhmann; Ivayla Apostolova; Philipp T Meyer; Jürgen Gallinat
Journal:  Dtsch Arztebl Int       Date:  2019-11-01       Impact factor: 5.594

4.  Nigral involvement in atypical parkinsonisms: evidence from a pilot study with ultra-high field MRI.

Authors:  Daniela Frosini; Roberto Ceravolo; Michela Tosetti; Ubaldo Bonuccelli; Mirco Cosottini
Journal:  J Neural Transm (Vienna)       Date:  2016-03-04       Impact factor: 3.575

Review 5.  Unexpected (123I)FP-CIT SPECT findings: SWIDD, SWEDD and all DAT.

Authors:  Balestrino Roberta; Barone Paolo; Filippi Massimo; Erro Roberto
Journal:  J Neurol       Date:  2021-09-18       Impact factor: 6.682

6.  Dopamine Transporter SPECT Imaging in Corticobasal Syndrome.

Authors:  Roberto Cilia; Carlo Rossi; Daniela Frosini; Duccio Volterrani; Chiara Siri; Cristina Pagni; Riccardo Benti; Gianni Pezzoli; Ubaldo Bonuccelli; Angelo Antonini; Roberto Ceravolo
Journal:  PLoS One       Date:  2011-05-02       Impact factor: 3.240

Review 7.  A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism.

Authors:  Flavia Niccolini; Marios Politis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-07-28       Impact factor: 9.236

8.  Diagnostic accuracy of imaging brain vesicular monoamine transporter type 2 (VMAT2) in clinically uncertain parkinsonian syndrome (CUPS): a 3-year follow-up study in community patients.

Authors:  San San Xu; Paschal K Alexander; Yenni Lie; Vincent Dore; Svetlana Bozinovski; Rachel S Mulligan; Kenneth Young; Victor L Villemagne; Christopher C Rowe
Journal:  BMJ Open       Date:  2018-11-15       Impact factor: 2.692

9.  Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates.

Authors:  Helen Ling; Ellen Gelpi; Karen Davey; Zane Jaunmuktane; Kin Y Mok; Edwin Jabbari; Roberto Simone; Lea R'Bibo; Sebastian Brandner; Matthew J Ellis; Johannes Attems; David Mann; Glenda M Halliday; S Al-Sarraj; J Hedreen; James W Ironside; Gabor G Kovacs; E Kovari; S Love; Jean Paul G Vonsattel; Kieren S J Allinson; Daniela Hansen; Teisha Bradshaw; Núria Setó-Salvia; Selina Wray; Rohan de Silva; Huw R Morris; Thomas T Warner; John Hardy; Janice L Holton; Tamas Revesz
Journal:  Acta Neuropathol       Date:  2020-01-16       Impact factor: 17.088
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.